Mount Sinai Builds a Specialized Capability Around the Needs of Amyloidosis Patients
Amyloidosis is a rare disease that is difficult to diagnose, often resulting in missed opportunities for early treatment that could have deterred damage to major organs, such as the heart, nervous system, kidneys, and gastrointestinal tract.